ETC - Current Challenges in Clinical Management and Drug Development in NASH

Starts:  Jun 17, 2021 10:00 AM (ET)
Ends:  Jun 18, 2021 5:00 PM (ET)

Course Description / Needs Statement

The conference, Current Challenges in Clinical Management and Drug Development in NASH has been designed to bring together liver scientists (translational researchers and clinical investigators) with strong expertise in fatty liver disease. The goals of this symposium are to: i) allow both communities to learn about each other’s progresses, ii) review the most recent preclinical and clinical investigations in their respective field and, iii) promote the rapid emergence of novel and efficient therapeutic options.

Program Chairs

  • Rohit Loomba, MD
  • Stephen A. Harrison, MD, FAASLD

Conference Format

The online live-streaming conference will have pre-recorded presentations for viewing along with live elements such as panel discussions, a poster session, and the opportunity to get your faculty questions answered in real time with both Chat and Q&A features available throughout the event.

Abstract submission

Those interested in NASH are encouraged to submit abstracts for this conference starting Monday, April 5, 2021. Selected abstracts will be designated as oral abstract presentations during the conference. To learn more, visit the Abstract Submission and Policies section.

Continuing Education

  • Continuing Medical Education (CME): 9.50 AMA PRA Category 1 Credits™
  • Maintenance of Certification: 9.50 ABIM MOC Points

Registration opens in May.

Program Agenda